Free Trial

West Pharmaceutical Services (WST) Stock Price, News & Analysis

-2.72 (-0.81%)
(As of 05/22/2024 ET)
Today's Range
50-Day Range
52-Week Range
671,265 shs
Average Volume
525,912 shs
Market Capitalization
$24.35 billion
P/E Ratio
Dividend Yield
Price Target

West Pharmaceutical Services MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
30.2% Upside
$435.20 Price Target
Short Interest
1.44% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.71mentions of West Pharmaceutical Services in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$50.85 M Sold Last Quarter
Proj. Earnings Growth
From $7.76 to $9.16 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.97 out of 5 stars

Medical Sector

9th out of 921 stocks

Surgical & Medical Instruments Industry

4th out of 91 stocks

WST stock logo

About West Pharmaceutical Services Stock (NYSE:WST)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

WST Stock Price History

WST Stock News Headlines

West to Host First-Quarter 2024 Conference Call
WST Apr 2024 450.000 call
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/1 Dividend
Last Earnings
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Supplies
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
5 Analysts


Net Income
$593.40 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.95 billion
Cash Flow
$9.93 per share
Book Value
$36.80 per share


Free Float
Market Cap
$24.35 billion

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

WST Stock Analysis - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" WST shares.
View WST analyst ratings
or view top-rated stocks.

What is West Pharmaceutical Services' stock price target for 2024?

5 brokerages have issued 12-month target prices for West Pharmaceutical Services' shares. Their WST share price targets range from $375.00 to $536.00. On average, they predict the company's share price to reach $435.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.
View analysts price targets for WST
or view top-rated stocks among Wall Street analysts.

How have WST shares performed in 2024?

West Pharmaceutical Services' stock was trading at $352.12 at the beginning of the year. Since then, WST shares have decreased by 5.1% and is now trading at $334.29.
View the best growth stocks for 2024 here

When is West Pharmaceutical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our WST earnings forecast

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) posted its quarterly earnings results on Thursday, April, 25th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.27. The medical instruments supplier earned $695.40 million during the quarter, compared to analyst estimates of $670.62 million. West Pharmaceutical Services had a net margin of 19.42% and a trailing twelve-month return on equity of 20.57%. The firm's quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.98 EPS.
Read the conference call transcript

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Thursday, April 25th. Investors of record on Wednesday, July 31st will be given a dividend of $0.20 per share on Wednesday, August 7th. This represents a $0.80 annualized dividend and a dividend yield of 0.24%. The ex-dividend date of this dividend is Wednesday, July 31st.
Read our dividend analysis for WST

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.23%. The company has been increasing its dividend for 31 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 10.55%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 8.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY 2024 earnings guidance on Thursday, April, 25th. The company provided EPS guidance of 7.630-7.880 for the period, compared to the consensus estimate of 7.620. The company issued revenue guidance of $3.0 billion-$3.0 billion, compared to the consensus revenue estimate of $3.0 billion.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.27%), Bank of New York Mellon Corp (4.50%), Price T Rowe Associates Inc. MD (2.79%), Bamco Inc. NY (1.22%), TD Asset Management Inc (0.85%) and Findlay Park Partners LLP (0.82%). Insiders that own company stock include Annette F Favorite, Bernard Birkett, Chad Winters, Charles Witherspoon, Cindy Reiss-Clark, Eric Mark Green, Quintin J Lai, Silji Abraham and Thomas W Hofmann.
View institutional ownership trends

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does West Pharmaceutical Services have any subsidiaries?
The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
This page (NYSE:WST) was last updated on 5/23/2024 by Staff

From Our Partners